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Summary
• Hepatitis C affects approximately 3% of the world population, with fatigue
being acknowledged as the cardinal symptom. Despite growing recognition that
hepatitis C fatigue impacts in a negative manner on quality of life, at the time of
this study no empirical information existed regarding the nature of this fatigue or
the way in which it affects a person’s life. Such information is needed to enable
nurses to engage in appropriate sensitive symptom management which is the core
nursing activity with this population, as to date there is no vaccine or widely
effective pharmacological therapy.
• The aim of the study was to ascertain the nature of hepatitis C fatigue.
• A qualitative approach using a grounded theory approach was employed.
Theoretical sampling generated 28 participants for in-depth interview. Data
analysis consisted of three coding processes, each type of coding having its own
purpose and method. Ethical approval was obtained, both from the principal
author’s academic institution and the participating health care institution.
• Hepatitis C fatigue emerged as being multidimensional in nature, with both
acute and chronic versions existing.
• The hepatology community is beginning to acknowledge the significant
prevalence of hepatitis C fatigue. This study provides a valuable insight into its
nature. This information can serve as resource for practitioners in their
development of interventions to enable the hepatitis C virus population live with
fatigue in a proactive manner.
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Introduction
Hepatitis C is one out of six viruses (A, B, C, D, E and
G) that together account for the majority of cases of
viral hepatitis. It can evoke a benign, asymptomatic
disorder with a mild course but may also cause
progressive liver disease, cirrhosis and primary liver
cancer (Dana et al., 1994; Tong et al., 1995; Strader &
Seeff, 1996; Fattovich et al., 1997; Hoofnagle, 1997).
The hepatitis C virus’ (HCV) propensity for chronicity
is unfortunately one of its most notable characteristics,
with approximately 85% of those infected developing
chronic infection (Hoofnagle, 1997). There is a wide
variation in its prevalence worldwide and the estimated
global incidence is 3%, or approximately 200 million
people (World Health Organisation, 1997). The most
efficient transmission of HCV is associated with percu-
taneous exposure to blood, but this does not account
for all cases. To date no vaccine or pharmacological
treatment capable of achieving widespread sustained viral
clearance has been developed.
Fatigue is a universal experience. It occurs in the old
and in the young, in humans and in animals. It varies in
intensity and occurs under different conditions and in
different situations (Eidelman, 1980). There is no inter-
disciplinary definition or common mechanism for classi-
fying fatigue, which is not always an unpleasant sensation
or related to a clinical condition. Indeed, for the vast
majority of people it serves a vital protective function, and
in this context is considered to be pleasant and welcome.
Fatigue ceases to be ‘normal’ when a person starts to view
it as a problem and begins the process of asking for help
to deal with it (Wessely et al., 1998). From a health
professional’s perspective, it can be a precursor, product
or a disease entity itself. It is acknowledged that fatigue
per se does not kill but that it can impair a person’s quality
of life. Despite its universality, varying status and impact,
it remains one of the least understood and neglected
symptoms by health professionals. Lewis & Wessely
(1992) believe that it may be a victim of a variant of
Tudor–Hart’s inverse care law – ‘an inverse interest law’ –
that is, the more the ordinary a condition, the less the
professional interest.
FATIGUE IN CHRONIC LIVER DISEASE
Although it is becoming increasingly acknowledged that
fatigue is prevalent and a key determining factor of the
health-related quality of life of individuals with chronic
liver disease, to date there has been a lack of any
appreciable research interest in this area (Huet &
Deslauriers, 1996; Huet et al., 1996; Cauch-Dudek et al.,
1998; Younossi et al., 1998; Prince et al., 1999). The
consequence of the latter is a general lack of understanding
regarding the aetiology, correlates and/or treatment of
liver disease fatigue. Fatigue is regarded as ‘a riddle
wrapped in a mystery inside an enigma’ by the majority of
hepatology health professionals (Jones, 1995, p. 1606).
Although no definitive confirmation had been achieved,
the pioneering physiology researchers in this area have
advanced a number of potential causes for liver disease-
related fatigue, such as decreased levels of corticotrophin-
releasing hormone, hypercytokinaemia, serum acylcarni-
tine and hyperammonaemia (Dietrich et al., 1990; Swain
& Maric, 1995, 1997; Plevris & Blair, 1997; Kuratsune
et al., 1998).
At the time of this research, possibly reflecting the
relative modernity of the disease, no empirical study could
be located that had hepatitis C associated fatigue as its
prime focus, although it was widely recognized to exist by
clinicians and patients alike (Dolan, 1997; Mahony, 1998;
Spray, 1998). Frequent but superficial reference was made
to it as the cardinal symptom that the symptomatic
population complained of, variably described as lethargy,
malaise, lack of energy or easy fatigability (Desmet et al.,
1994; Di Bisceglie et al., 1995; Shakil et al., 1995;
Hoofnagle, 1997). Retrospective chart reviews placed its
prevalence between 45% and 66% (Lee et al., 1997;
Kenny-Walsh, 1999). A descriptive-exploratory study was
subsequently carried out with members of the Irish
hepatitis C population that confirmed the presence of
fatigue and indicated that it had a negative impact on their
health-related quality of life (Glacken et al., 2001). The
decision to focus solely on the hepatitis C population was
influenced by the fact that compared with any of the other
hepatitis viruses, a substantial proportion (70–80%) of
those infected go on to develop chronic HCV and
therefore are at risk of experiencing fatigue, as this
symptom is a recognized accompaniment of chronic
hepatitis C infection. Secondly, there is no indication
either empirically or anecdotally that those with any of the
other hepatitis viruses experience fatigue to an appreciable
extent.
In view of the fact that to date there is no vaccine or
widely available effective pharmacological treatment for
HCV, it was clear that fatigue management would become
one of the core nursing activities with patients and their
families in the future. In order to engage effectively in this
activity, an in-depth understanding of the experience of
fatigue was required.
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Methodology
RESEARCH QUESTION
What is the nature of the fatigue that individuals with
hepatitis C experience?
RESEARCH DESIGN
Acknowledging the immaturity of the concept of fatigue in
the hepatology literature and the questions set for explo-
ration, a qualitative research approach was adopted, namely
grounded theory. Qualitative methods recognize that a
concept cannot be divorced from its context. Monk’s (1989)
study of fatigue in rheumatoid arthritis clearly delineated
that the context of fatigue is crucial to its definition because
of its quality-giving characteristics. Grounded theory was
chosen over other qualitative methodologies because of its
recognized suitability for eliciting processes and changes
over time, allowing appreciation of the possible evolving
nature of the concept under examination (Gift, 1997). An
earlier exploratory study indicated that this may be a
feature of hepatitis C fatigue (Glacken et al., 2001). The
techniques of grounded theory also accommodate the
formation and linking of categories, identification of
negative cases and comparison of different contexts or
populations (Morse et al., 1997). It was believed that these
features would all contribute to yielding a comprehensive
description and understanding of hepatitis C associated
fatigue. The methodological principles of grounded theory
as advanced by Strauss & Corbin (1990) were followed.
SAMPLE
In keeping with grounded theory, theoretical sampling was
employed. In contrast to other forms of sampling, the
principal concern of sampling was with the representa-
tiveness of the emerging concepts in their varying forms.
The researcher was looking for events and incidents that
were indicative of the phenomena being studied, and was
not counting individuals. The sampling process was
directed by the aim of each of the three coding procedures
– open, axial and selective. Notable features of the process
were its cumulative nature and that its depth of focus
increased as the research study progressed. Theoretical
saturation was achieved following 26 interviews and
secondary analysis of the transcripts of two interviews
previously carried out by the principal author in an earlier
study (Glacken et al., 2001) (Table 1).
Eight out of 28 participants were male, with partici-
pants varying in age from 36 to 64 years. The majority
(n ¼ 24) were viraemic. Primarily, participants were
infected with HCV as a result of receiving infected
blood/plasma transfusions or through needle sharing
during the use of illicit intravenous drugs. In two cases
the source of HCV could not be established.
ETHICS
Ethical issues in relation to human research in general,
which the International Council of Nurses (1996) have
delineated as the right not to be harmed, right of full
disclosure, right of self-determination, right of privacy
and confidentiality, were respected. Ethical approval was
received from the principal author’s associated university
and from the hospital which served as the source of access
to participants.
DATA GENERATION AND ANALYSIS
The mode of data generation employed was in-depth
interviewing, although in reality, as in any grounded
theory study, data generation was not distinct from data
analysis. In keeping with interviewing in the interactionist
tradition, the primary goal was to give authentic insight
into participants’ experiences (Silverman, 1993; Charmaz,
1995). The interviews were tape-recorded where the
setting and participants permitted (n ¼ 24); otherwise
notes were taken and the interview written up immediately
afterwards (n ¼ 4). The average length of interviews was
80 minutes (range 50–180). A minimum of an additional
30 minutes was spent with each of the participants as a
debriefing session following the interviews. These sessions
were not recorded. Data analysis consisted of three coding
processes, each type of coding having its own purpose and
methodology. With the exception of the very early stages
in the study, the coding processes were not always
employed as separate entities in the analysis and therefore
the researcher was employing at times all three types of
coding concurrently. Two analytical procedures served as
the mutual bedrock for all the coding processes, namely
Table 1 Theoretical sampling process
Invited to participate Interviewed
Open coding (time 1) 15 12
Axial coding (time 2) 8 8
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making constant comparisons and asking questions of the
data. The questions generated were subsequently posed as
hypotheses, with verification being sought in the data. It is
believed that these procedures enabled the researcher
to give the emerging concepts depth and specificity.
Throughout the study, the first author kept written
memos and used diagrams to help formulate her thoughts
and make visual links between emerging categories.
TRUSTWORTHINESS OF FINDINGS
The trustworthiness of the data was established through a
number of strategies: member checks, development of an
audit trail of the analytical processes, continuous use of
Paterson’s (1994) reactivity analysis framework and enlist-
ing the assistance of an individual who was Master’s
prepared and had expert knowledge of the hepatitis C
population to challenge the researcher on the robustness of
the categories that were being advanced. This latter strategy
resulted in pursuing some different avenues so that more
complete interpretations of the data could be advanced.
Findings
The research question posed was in relation to the nature
of the fatigue that the hepatitis C population experience.
The majority of the participants were unable to share this
knowledge in a nominal form but only through the use of
metaphors, comparisons with the norm or as a precursor
of a reduction in an activity or a treasured role:
It is like on one hand if someone is pouring concrete
into you and it is weighing you down but on the other
hand it is like feeling almost like you are coming out
of an anaesthetic; you know you are in those two
worlds, trying to grasp onto the normal world and
not being able to leave that other world.
This difficulty in articulating the fatigue experience,
and hence the use of metaphors to demonstrate its qualities
has also emerged in other studies (Ferrell et al., 1996;
Pearse & Richardson, 1996; Ream & Richardson, 1997).
The major sentiment that emerged from the data and
encapsulated participants’ perceptions of the nature of the
fatigue was that it was a pernicious experience in its onset,
nature, dimensions and severity. No universal fatigue
trajectory emerged, with some participants being able to
isolate an exact date for its onset and detail its subsequent
course:
In 1992, things changed. I started to get aches and
pains and tiredness and the tiredness was not
anything to do with me feeling low or anything it was
different. It has just progressed over the years.
Others, however, experienced its evolution as a more
insidious process.
NATURE OF FATIGUE
The fatigue was considered by participants to be discern-
ible from their understanding of ‘normal fatigue’ in that it
was arresting, ageing, impregnable and invincible, the
difference frequently being likened to ‘night and day’:
You cannot fight it; it is not a tiredness that you
can fight like a normal tiredness. A normal tiredness,
you can fight it and get a second wind or if you had a
few cups of coffee, it would keep you going. None
of this works with this tiredness.
The most distinguishing feature of the fatigue, that of
two distinct types, emerged as data generation and coding
progressed. This led to further theoretical sampling for
verification of their existence. The two distinct classes of
fatigue will be subsequently referred to as chronic and
idiopathic:
There are two levels of tiredness, there is just
ordinary tiredness that I think everybody has and
there is…what I call the ‘sick tiredness’. It is like you
are not just tired, but you are sick, but you have not
got any sickness. Yes, you feel sick, you feel like you
have had a really bad dose of the flu, and you are
trying to come out of it, but you are not coming out
of it, but you haven’t had the flu, you know what I
mean. and it is like somebody has poured a jug of
concrete into me and there is this weight that I
cannot overcome.
There are two kinds …Tiredness and exhaustion and
where as I say the exhaustion doesn’t come all the
time to you. I could be just tired. With the exhaustion
you feel defeated…It is a weird feeling. You just feel
that your whole body just breaks down. It is not your
own. Your head is there but your body is not your
own. You just want to do things but you cannot.
One of the most contrasting features of the two types of
fatigue was in terms of the property, status, whose dimen-
sions ranged from permanent to temporary. Chronic fatigue
seemed to be a permanent feature in participants’ lives:
I am permanently tired. It is present even on
wakening every morning.
I am like an old engine trying to get started in the
morning, trying to stoke myself up. It could take me
2 or 3 hours to get going.
The intensity of the chronic fatigue appeared to vary. For
some, a distinct daily fatigue trajectory could be outlined,
with span of severe fatigue lasting a number of hours,
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where for others it was a constant low grade fatigue that
was manageable if certain strategies were employed, and
provided the flavour or background to their ‘good days’.
In contrast, the temporary fatigue was a transient but
recurring fatigue in their lives, which had two equally
distressing features. First was its unpredictability both in
occurrence and duration, and second was its intensity,
which was so acute that it had the ability to strip
participants completely of their feeling of control. The
consequence was that life and all it entailed at that
particular time had to be put on hold until the idiopathic
fatigue was defunct for that particular occasion:
I might have a couple of months; 3 or 4 months going
grand or maybe 6 weeks even, fine. Full of beans and
I can do anything and then all of a sudden, bang
and there it is … and then you wake up one morning,
and you say ‘Oh, God, I feel much better today, and
it is gone’. I don’t know what triggers it to go. I can
feel it coming on sometimes but it just goes away
without warning and I don’t know why it just goes
away. Whether you have had enough of your resting,
time to rejuvenate or whatever. I don’t know, I really
don’t know…don’t understand it, because there is
nothing, nothing different going on [in your life].
The oppressive nature of this fatigue was compared
with being in a ‘fog’ that one was struggling to get out or
experiencing a very hot climate with its accompanying
humidity, and when the idiopathic fatigue disappeared, it
was like breathing in fresh air. It was considered to be
unpleasant because of its uncontrollable nature and viewed
as so intrusive that one participant felt she would not want
to live if it was present all the time. The onset, particularly
if it was physically orientated, seemed to have the capacity
to demand instant attention from those experiencing it,
frequently articulated as desperate need to lie down. One
questionnaire explained, ‘I just need to lie down. I just
have to go to bed’.
Although both types of fatigue were different, from a
location perspective, hepatitis C associated fatigue was
unanimously experienced as a whole body feeling. It was a
fatigue that penetrated the entire body, as if it emanated
from the very core of their being. This feature differen-
tiated it from participants’ conceptualization of normal
fatigue, which manifests itself locally:
The fatigue seems to invade every crevice of your
body, everything is affected.
DIMENSIONS
Both types of fatigue were multidimensional in nature,
with physical, cognitive and affective dimensions, although
their significance in terms of their degree of intensity were
unique to the individual. Although it was evident from the
participants that the physical dimension of their fatigue
was the most disconcerting.
PHYSICAL DIMENSION
A feeling of heaviness was the over-arching way fatigue
manifested itself, participants at times believing that they
could ‘collapse with the weight’ of their bodies:
It is a feeling of heaviness. I just feel I am going to
collapse with the weight of my body. It is like
something continually dragging out of you.
Weakness also manifested itself as an intrinsic compo-
nent of the physical dimension. Weakness is not regarded
as a feature of the fatigue experienced by healthy
populations but is accepted as an inherent feature of the
fatigue of some unhealthy populations, such as those with
various carcinomas (Glaus, 1996), for example:
When I get tired I have a terrible weakness. I shake
like a leaf.
The fatigue was also discernible by its draining capacity
and ability to sap participants of their energy:
When I was depressed, I had this sort of paralysis,
I couldn’t do things, had lost interest but I have not
now. I still have all my interests but I have not the
energy to do them and I suppose that is physical.
I play guitar and banjo and there are days when
I wouldn’t have the energy to pick them up.
Similarly, it also robbed participants of stamina, which
subsequently curtailed their ability to engage in certain
activities. An aching sensation also accompanied the
fatigue, with participants recounting that ‘every part of
me aches’. It appeared difficult for them to discern the
origin of this sensation, that is, whether it was skeletal or
muscular in origin, although it was acknowledged that the
fatigue had the capacity to activate or augment the severity
of existing pain:
When I get tired, I can feel the pain gradually coming
on. I refer to it as liver pain.
COGNITIVE DIMENSION
Hepatitis C fatigue also has a well-defined cognitive
dimension, although the majority of participants attrib-
uted less significance to this. The reasons were not clear
but could be because the fatigue manifested itself less
frequently or intensely in this manner or more control
could be achieved over it, as certain activities could be
employed to neutralize its effects, such as writing things
down to offset forgetfulness. Forgetfulness and lack of
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concentration appeared the most universal aspects of the
cognitive dimension:
Stupid is the only word for it. Thick, kinda. A bit
forgetful as well. It is very annoying. I have no
concentration. I cannot learn during that time. I
cannot read for any length of time, because. I just
sort of lose it a bit.
According to one man, it was not a physical fatigue
form but was more ‘a mental thing really – it is like a few
notches have been chopped off your IQ’.
AFFECTIVE SENSATION
Participants were judiciously conscious of the affective
dimension of their fatigue experience as they found this
aspect particularly distressing to tolerate. An array of
emotions appeared to be entangled in their fatigue such as
anger, frustration and anxiety:
Something comes upon me (when I am tired). People
say I get a bit of a temper. Sometimes I am so bad
tempered…what would come out of my mouth
would shock me, myself.
Although the goal of the methodology employed was
not to determine causality, it did seem that the fatigue
experienced could be an instigator of ‘depressed mood’.
SEVERITY
Participants did not judge the severity of the fatigue
experience solely by its intensity. Instead, severity was
considered a combination of intensity, duration and
frequency. The fatigue appeared to be tolerated by them
if it did not require them to relinquish total control of
their daily activities. Conversely, it was perceived as
intolerable and severe in nature when its presence required
them to relinquish control over the totality of their daily
activities:
You know I could put up with this fatigue…even
every day, if I knew it would only be there for an
hour or two. I could manage to do things around it
but its when it comes and doesn’t lift for days, I really
feel defeated. Everything has to be shelved. I just feel
everything is beyond my reach, beyond my control,
I suppose.
Discussion
The findings clearly demonstrate that the fatigue experi-
enced by the hepatitis C population is multidimensional.
Its most distinguishable feature is the existence of two
distinct types of fatigue – chronic and idiopathic which
appear to be universally experienced. To date, the
experience of fatigue has not been studied in any other
hepatitis populations. Indeed, the only hepatology popu-
lation’s fatigue that has been attended to in the literature is
that of those with primary biliary cirrhosis, but unfortu-
nately this is only in terms of its prevalence and possible
correlates (Huet & Deslauriers, 1996; Huet et al., 1996).
This dearth of information prevents the fatigue experi-
enced by those with hepatitis C being compared with that
of any other hepatology population. Indeed, given the
acknowledged significant prevalence of fatigue in the
chronic illness population as a distinct entity (Wessely
et al., 1998), a negligible amount of knowledge on fatigue
has been generated inductively. The studies that do exist
primarily focus on the fatigue of cancer patients (Ferrell
et al., 1996; Glaus et al., 1996; Pearse & Richardson, 1996;
Ream & Richardson, 1997; Rose et al., 1998; Small &
Lamb, 1999). Despite this, some similarities can be drawn
between hepatitis-associated fatigue and that experienced
by other populations. It is multidimensional in nature,
with similar dimensions being described, although the
significance that the various populations attribute to each
dimension is not known at this stage. It would also seem
that the physical element of fatigue is experienced
universally as a whole-body-sensation. Some elements of
hepatitis C associated fatigue, such as ‘aching’, do not
appear to be a universal experience, although they are
evident in some patient populations (Schaefer & Potyl-
cycki, 1993; Ream & Richardson, 1997). Weakness,
another attribute of hepatitis C fatigue, was also found
in a German cancer population (Glaus, 1996). From the
qualitative literature available, it appears that the fatigue of
various patient populations shares many commonalties but
differs in some aspects. Further in-depth study is required
before any firm inferences can be drawn.
While conceding this dearth of information, it is accepted
that in any one situation there are many potential
mechanisms that contribute to fatigue in chronic illness.
The most unambiguous categorization of these potential
mechanisms is into (i) specific biological mechanisms such as
disease activity and treatment and (ii) general mechanisms
such as depression, sleep disturbances and pain (Wessley
et al., 1998). The original cause of fatigue in a disease may
differ from factors which perpetuate it. In patients with
chronic systemic diseases such as hepatitis C, it is likely that
fatigue is first experienced as a direct result of the disease
process and then as a corollary of the disease as it becomes
more chronic, with secondary factors such as inactivity,
other symptoms and disability perpetuating the fatigue.
Hepatology nurses are the health care professionals with
the principal responsibility for assisting hepatitis C
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patients to manage their fatigue. They therefore require
in-depth knowledge of the experience of the symptom. In
order to attain this knowledge they undertake further
research, both as a sole activity and in collaboration with
others, to ascertain what are the primary and secondary
factors in relation to the fatigue experience and how they
are linked. The study detailed in this paper could serve as
a starting point. It will also provide a proportion of the
knowledge required to begin designing and/or instigating
appropriate interventions that allow those affected to live
with their fatigue in a proactive manner. When the results
of recent studies addressing the prevalence of fatigue in
the hepatitis C population are taken into account, the need
to develop effective fatigue interventions is very apparent.
Prevalence rates ranging from 67% to 92% have been
reported from studies carried out in diverse locations, with
varying sources of HCV infection and disease severity
(Ahmad et al., 1999; Barkhuizen et al., 1999; Goh et al.,
1999; Tanguy et al., 1999; Glacken, 2000).
Surprisingly, although many interventions are sugges-
ted to relieve fatigue, to date few have been subjected to
empirical testing (Portenoy & Itri, 1999; Ream &
Richardson, 1999). The literature suggests that because
of the multidimensional, multifactorial nature of hepatitis
C fatigue, a multimodal intervention that could be tailored
to the individual may be the most appropriate (Lorig et al.,
1994; Ream & Richardson, 1999; van Mens-Verhulst
et al., 1999). This may include, when all the contributing
factors to the fatigue experience have been identified, both
pharmacological and non-pharmacological components.
An interdisciplinary approach may also be required. To
date, pharmacological therapies for fatigue associated with
medical conditions have not been subjected to rigorous
evaluation, although advancements have been made in the
multiple sclerosis population, where the antiviral agent,
amantadine hydrocloride, is proving effective (Murray,
1985). Reflecting the newness of hepatitis C, negligible
research has been carried out, although, through a case-
study approach, long-term ondansetron has been found to
ameliorate hepatitis C fatigue (Jones, 1999). The non-
pharmacological component of intervention could take
an eclectic approach and include empirically supported
strategies such as those addressing energy conservation,
sleep management, nutrition support, exercise and psy-
chotherapeutic strategies (Chadler et al., 1997; Gerber
et al., 1987; Neuberger et al., 1997; Price & Couper,
2001).
Hepatology nurses should appreciate that management
of fatigue should include a comprehensive evaluation that
assesses severity (Portenoy & Itri, 1999; Tiesinga et al.,
1999). Fatigue is a dynamic process that often requires
changes in strategies over time. The changes may emanate
from a change in the nature of fatigue itself or in response
to the individual’s lack of acceptance of a strategy or desire
to try something new. The emergence of new empirically
based knowledge may also herald the introduction of new
strategies or combinations. It should also be recognized
that the success of any fatigue management programme
will depend on many factors, including the quality of the
client–practitioner partnership, and that truly listening to
the patient, as was attempted in this inquiry, is the basis
for high quality relationships.
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